Surgical adhesive shows promise in bypass
This article was originally published in Clinica
Researchers in the US have successfully used CryoLife's protein-based surgical adhesive BioGlue to attach vein grafts in experimental bypass surgery performed on goat hearts. The technique could one day be used to re-attach coronary arteries without sutures in minimally-invasive human heart surgery, making the procedure easier and less expensive, says CryoLife president and CEO Steven Anderson.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.